Back to WA Weiss Asset Management LP
AVDL
2 quarters
Position history for WAWeiss Asset Management LP's holdings in AVADEL PHARMACEUTICALS
As of its Q4 2025 13F, Weiss Asset Management held 4,515,114 shares of AVDL (Avadel Pharmaceuticals), worth $97.3M. AVDL was 1.3% of Weiss Asset Management's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$97.3M
Total Shares Change
-4.5M
Quarter-by-Quarter History